Home › Companies › Bioneer

Bioneer

바이오니아 · 064550 · KOSDAQ
Filings, last 12 months
36
Supply contracts
0
Insider reports
12
Share & bond issues
0

At a glance

Bioneer filed 36 disclosures in the last 12 months, including 12 insider, 2 5% holder and 1 earnings. The most recent key filing was on Oct 12: Director's holding rose by 1,000 sh (other change).

Revenue for 2025 was ₩330B, up 12.3% on 2024. Operating margin was 4.6% against -4.6% a year earlier. Debt was 63% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩178B and operating profit of ₩650.3M.

The 2025 annual report lists 362 employees with an average tenure of 7.1 years and average pay of ₩52.4M, #1344 of 1,829 listed companies by average pay. Its 7 directors and auditors were paid ₩278M each on average. It paid no cash dividend for 2025. 박한오 and related parties held 18.06% at year end.

From the 2025 annual report

Employees
362
Average pay
₩52.4M
Average tenure
7.1 yrs
Avg. director pay
₩278M

Staff: 362 (211 men, 151 women), of whom 9 on fixed-term contracts. Total pay for the year: ₩19B. Directors and auditors: 7, paid ₩1.9B in total.

No cash dividend was paid for 2025.

Largest shareholder

박한오 holds 13.71%; with 11 related parties the group holds 18.06% of common shares at year end.

Individuals paid ₩500M or more

박한오 대표이사₩1.2B

Auditor: 삼일회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

2023
Revenue ₩263B
Op. profit ₩791.8M
Debt/equity 34%
2024
Revenue ₩294B
Op. profit -₩13.4B
Debt/equity 46%
2025
Revenue ₩330B
Op. profit ₩15.2B
Debt/equity 63%
2026 H1
Revenue ₩178B
Op. profit ₩650.3M
Debt/equity 70%
RevenueOperating profitOperating lossConsolidated where available · from periodic reports

Key filings

Other filings

Links open the original filing on DART, in Korean.